Current issue
- Page Path
-
- HOME
- BROWSE ARTICLES
- Current issue
|
- Special Issue
- KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
- Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang, on behalf of The Korean Association for the Study of the Liver (KASL)
- Clin Mol Hepatol. 2025;31(Suppl):S1-S31. Published online February 19, 2025
- Reviews
- Epidemiology of metabolic dysfunction-associated steatotic liver disease
- Zobair M. Younossi, Markos Kalligeros, Linda Henry
- Clin Mol Hepatol. 2025;31(Suppl):S32-S50. Published online August 19, 2024
- Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- Clin Mol Hepatol. 2025;31(Suppl):S51-S75. Published online June 27, 2024
- Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease
- Andrea Caddeo, Stefano Romeo
- Clin Mol Hepatol. 2025;31(Suppl):S76-S93. Published online August 5, 2024
- Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease
- Huma Saeed, Luis Antonio Díaz, Antonio Gil-Gómez, Jeremy Burton, Jasmohan S. Bajaj, Manuel Romero-Gomez, Marco Arrese, Juan Pablo Arab, Mohammad Qasim Khan
- Clin Mol Hepatol. 2025;31(Suppl):S94-S111. Published online November 28, 2024
- Alcohol-associated liver disease: Natural history, management and novel targeted therapies
- Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós-Ginès, Ana Clemente-Sánchez, Hugo López-Pelayo, Ramón Bataller
- Clin Mol Hepatol. 2025;31(Suppl):S112-S133. Published online October 31, 2024
- Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0
- Di Wu, Jia-Horng Kao, Teerha Piratvisuth, Xiaojing Wang, Patrick T.F. Kennedy, Motoyuki Otsuka, Sang Hoon Ahn, Yasuhito Tanaka, Guiqiang Wang, Zhenghong Yuan, Wenhui Li, Young-Suk Lim, Junqi Niu, Fengmin Lu, Wenhong Zhang, Zhiliang Gao, Apichat Kaewdech, Meifang Han, Weiming Yan, Hong Ren, Peng Hu, Sainan Shu, Paul Yien Kwo, Fu-sheng Wang, Man-Fung Yuen, Qin Ning
- Clin Mol Hepatol. 2025;31(Suppl):S134-S164. Published online January 22, 2025
- Prospect of emerging treatments for hepatitis B virus functional cure
- Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2025;31(Suppl):S165-181. Published online November 14, 2024
- Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
- Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
- Clin Mol Hepatol. 2025;31(Suppl):S182-S195. Published online November 21, 2024
- Hepatitis E as a trigger for acute-on-chronic liver failure
- Maria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, Mar Riveiro-Barciela
- Clin Mol Hepatol. 2025;31(Suppl):S196-S204. Published online November 11, 2024
- Prediction and prevention of post-procedural bleedings in patients with cirrhosis
- Alix Riescher-Tuczkiewicz, Pierre-Emmanuel Rautou
- Clin Mol Hepatol. 2025;31(Suppl):S205-S227. Published online February 18, 2025
- Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
- Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang
- Clin Mol Hepatol. 2025;31(Suppl):S228-S254. Published online December 26, 2024
- Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications
- Jaeho Park, Yi-Te Lee, Vatche G. Agopian, Jessica S Liu, Ekaterina K. Koltsova, Sungyong You, Yazhen Zhu, Hsian-Rong Tseng, Ju Dong Yang
- Clin Mol Hepatol. 2025;31(Suppl):S255-S284. Published online November 28, 2024
- Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia
- Clin Mol Hepatol. 2025;31(Suppl):S285-S300. Published online August 19, 2024
- Prediction and management of small-for-size syndrome in living donor liver transplantation
- Jia-hao Law, Alfred Wei-Chieh Kow
- Clin Mol Hepatol. 2025;31(Suppl):S301-S326. Published online December 10, 2024
- Liver organoids: Current advances and future applications for hepatology
- Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi
- Clin Mol Hepatol. 2025;31(Suppl):S327-S348. Published online December 26, 2024
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
